Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Treasury Shares: 2022-2024

Historic Treasury Shares for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Dec 2024 value amounting to $1.5 million.

  • Centessa Pharmaceuticals' Treasury Shares fell 22.54% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year decrease of 22.54%. This contributed to the annual value of $1.5 million for FY2024, which is 22.54% down from last year.
  • As of FY2024, Centessa Pharmaceuticals' Treasury Shares stood at $1.5 million, which was down 22.54% from $1.9 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Treasury Shares ranged from a high of $1.9 million in FY2023 and a low of $1.5 million during FY2024.
  • Its 3-year average for Treasury Shares is $1.8 million, with a median of $1.8 million in 2022.
  • In the last 5 years, Centessa Pharmaceuticals' Treasury Shares grew by 8.02% in 2023 and then decreased by 22.54% in 2024.
  • Over the past 3 years, Centessa Pharmaceuticals' Treasury Shares (Yearly) stood at $1.8 million in 2022, then grew by 8.02% to $1.9 million in 2023, then fell by 22.54% to $1.5 million in 2024.